SNDL Inc
F:VY4

Watchlist Manager
SNDL Inc Logo
SNDL Inc
F:VY4
Watchlist
Price: 1.28 EUR 0.71% Market Closed
Market Cap: 338.3m EUR

P/E
Price to Earnings

-5.6
Current
-4.6
Median
20.6
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-5.6
=
Market Cap
336.7m EUR
/
Net Income
-94.8m CAD
Market Cap P/E
CA
SNDL Inc
F:VY4
336.7m EUR -5.6
US
Eli Lilly and Co
NYSE:LLY
797.8B USD 74.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
US
Johnson & Johnson
NYSE:JNJ
372.6B USD 17.1
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 19.6
CH
Roche Holding AG
SIX:ROG
214.2B CHF 25.9
CH
Novartis AG
SIX:NOVN
189.9B CHF 19.3
UK
AstraZeneca PLC
LSE:AZN
163.5B GBP 28
US
Merck & Co Inc
NYSE:MRK
212.7B USD 12.2
IE
Endo International PLC
LSE:0Y5F
163.5B USD -56
US
Pfizer Inc
NYSE:PFE
136.5B USD 17.3
Earnings Growth PEG
CA
SNDL Inc
F:VY4
Average P/E: 26.7
Negative Multiple: -5.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
74.5
49%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.1
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
19.6
18%
1.1
CH
Roche Holding AG
SIX:ROG
25.9
32%
0.8
CH
Novartis AG
SIX:NOVN
19.3
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28
36%
0.8
US
Merck & Co Inc
NYSE:MRK
12.2
18%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.3
29%
0.6

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-65.1
2-Years Forward
P/E
-16.3
3-Years Forward
P/E
-24.4